| Aug 22 |
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term
|
| Aug 6 |
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
|
| Aug 5 |
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
|
| Aug 5 |
Unlocking Qiagen (QGEN) International Revenues: Trends, Surprises, and Prospects
|
| Aug 1 |
Qiagen N.V. (QGEN) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
QIAGEN (QGEN) Q2 Earnings Surpass Estimates, Margins Crash
|
| Aug 1 |
Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key Metrics
|
| Jul 31 |
Qiagen (QGEN) Tops Q2 Earnings and Revenue Estimates
|
| Jul 31 |
Qiagen: Q2 Earnings Snapshot
|
| Jul 31 |
Qiagen Non-GAAP EPS of $0.55 beats by $0.03, revenue of $496M beats by $1.36M
|
